ICISConnect

Browse by Tags

No immunity from credit crisis

There is no way that Indian chemical companies can escape from the global financial crisis. Tough times lie ahead as companies will be hit on all fronts - high cost of credit, falling demand as the global economy slows down and increased supply once new capacities in Asia and the Middle East get commissioned...

Posted to ICIS Blogs (Weblog) by Anonymous on 10-10-2008
Dow jv hits a roadblock

India's Foreign Investment Promotion Board (FIPB) has deferred making a decision on a proposed chloromethanes joint venture between a subsidiary of Dow Chemical and Gujarat Alkalies and Chemicals Ltd (GACL) as the government would like more time 'to examine the proposal', reports ICIS news...

Posted to ICIS Blogs (Weblog) by Anonymous on 08-20-2008
Time to wake up to climate change

India is known to move slowly. So it is perhaps not surprising to read that most local companies have yet to formulate strategies to face the challenge of climate change. KPMG recently released a report on a study carried out earlier this year to understand if Indian business leaders are aware of the...

Posted to ICIS Blogs (Weblog) by Anonymous on 07-30-2008
Reliance for carbon fibre?

Reliance Industries is reported be looking at sourcing technology from India's National Aersospace Laboratories (NAL) to build a 4000 tonnes/year carbon fibre plant at Vadodara. NAL had set up a 20 tonnes/year plant in Bangalore in 2006 with the material used for light combat aircraft, missile and...

Posted to ICIS Blogs (Weblog) by Anonymous on 07-15-2008
Watch Out!

It is time for the Indian chemical industry to wake up to the threat of increased flow of downstream chemicals from the Middle East. Countries such as Saudi Arabia are aggressively pushing for the development of a petrochemicals industry that goes beyond olefins and polyolefins. State-owned and private...

Posted to ICIS Blogs (Weblog) by Anonymous on 06-19-2008
Sign of things to come?

The big news today is Daiichi Sankyo's acquisition of a controlling stake in Ranbaxy , India's largest pharmaceutical company, for $4.6bn. Analysts have been quick to predict many more such deals which will see international pharma majors entering the generic space. Indian generic players have...

Posted to ICIS Blogs (Weblog) by Anonymous on 06-12-2008
Atul inks polymer additives deal with DSM

Atul has successfully secured a contract manufacturing deal with Stamicarbon and DSM Licensing Centre for phosgene-based polymer performance additives used in polyamides. Atul will manufacture the additives based on guidelines given by Stamicarbon with DSM marketing the product worldwide under its brand...

Posted to ICIS Blogs (Weblog) by Anonymous on 06-03-2008
Spotlight on Bhopal

Indian papers and news channels are once again buzzing with reports about Dow Chemical and Bhopal. This time it is about the law ministry's view on whether the company should clean up the Bhopal site. The law ministry's comments on a note to the Prime Minister's office were obtained by activists...

Posted to ICIS Blogs (Weblog) by Anonymous on 05-14-2008
The caustic-chlorine dilemma

Indian demand for caustic soda has been steadily expanding thanks to the alumina sector but investments in new chlor-alkali facilities are being held back by limited demand growth for chlorine. As is usually the case, India’s low per capita consumption suggests immense opportunity for growth. India...

Posted to ICIS Blogs (Weblog) by Anonymous on 05-12-2008
Will Gujarat gain from Beijing clean up?

China’s move to clean up Beijing ahead of the Olympics is likely to have far reaching repercussions for the Indian chemicals industry. ICIS news reported today that the Chinese government was regulating the production and sale of more than 257 chemicals around Beijing - a move that could result in the...

Posted to ICIS Blogs (Weblog) by Anonymous on 05-02-2008

Page 1 of 2 (17 items) 1 2 Next >